BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasumova GG, Tabatabaie O, Najarian RM, Callery MP, Ng SC, Bullock AJ, Fisher RA, Tseng JF. Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy. Ann Surg. 2017;266:625-631. [PMID: 28692469 DOI: 10.1097/sla.0000000000002385] [Cited by in Crossref: 55] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Widmann B, Warschkow R, Beutner U, Weitzendorfer M, Ukegjini K, Schmied BM, Tarantino I, Steffen T. Effect of lymphadenectomy in curative gallbladder cancer treatment: a systematic review and meta-analysis. Langenbecks Arch Surg 2020;405:573-84. [PMID: 32458141 DOI: 10.1007/s00423-020-01878-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yan Y, Lin J, Zhang M, Liu H, Zhou Q, Chen R, Wen K, Wang J, Xiao Z, Mao K. A Novel Staging System to Forecast the Cancer-Specific Survival of Patients With Resected Gallbladder Cancer. Front Oncol 2020;10:1281. [PMID: 32850391 DOI: 10.3389/fonc.2020.01281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wencong M, Jinghan W, Yong Y, Jianyang A, Bin L, Qingbao C, Chen L, Xiaoqing J. FOXK1 Promotes Proliferation and Metastasis of Gallbladder Cancer by Activating AKT/mTOR Signaling Pathway. Front Oncol 2020;10:545. [PMID: 32363163 DOI: 10.3389/fonc.2020.00545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Sung YN, Song M, Lee JH, Song KB, Hwang DW, Ahn CS, Hwang S, Hong SM. Validation of the 8th Edition of the American Joint Committee on Cancer Staging System for Gallbladder Cancer and Implications for the Follow-up of Patients without Node Dissection. Cancer Res Treat 2020;52:455-68. [PMID: 31623417 DOI: 10.4143/crt.2019.271] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
5 Saluja SS, Nekarakanti PK, Mishra PK, Srivastava A, Singh K. Prospective Randomized Controlled Trial Comparing Adjuvant Chemotherapy vs. No Chemotherapy for Patients with Carcinoma of Gallbladder Undergoing Curative Resection. J Gastrointest Surg 2021. [PMID: 34545545 DOI: 10.1007/s11605-021-05143-6] [Reference Citation Analysis]
6 Matsukuma S, Tokumitsu Y, Shindo Y, Matsui H, Nagano H. Essential updates to the surgical treatment of biliary tract cancer. Ann Gastroenterol Surg 2019;3:378-89. [PMID: 31346577 DOI: 10.1002/ags3.12266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
7 Yu TN, Mao YY, Wei FQ, Liu H. Cystic duct cancer: Should it be deemed as a type of gallbladder cancer? World J Gastroenterol 2019; 25(44): 6541-6550 [PMID: 31802833 DOI: 10.3748/wjg.v25.i44.6541] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Yang Y, Tu Z, Ye C, Cai H, Yang S, Chen X, Tu J. Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study. BMC Surg 2021;21:59. [PMID: 33485332 DOI: 10.1186/s12893-021-01068-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Perlmutter BC, Naples R, Hitawala A, McMichael J, Chadalavada P, Padbidri V, Haddad A, Simon R, Walsh RM, Augustin T. Factors that Minimize Curative Resection for Gallbladder Adenocarcinoma: an Analysis of Clinical Decision-Making and Survival. J Gastrointest Surg 2021. [PMID: 33565014 DOI: 10.1007/s11605-021-04942-1] [Reference Citation Analysis]
10 Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis 2020;11:871. [PMID: 33067424 DOI: 10.1038/s41419-020-03080-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
11 Zhang M, Zhang P, Zhou K, Li Q. Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review. Front Oncol 2019;9:1180. [PMID: 31788447 DOI: 10.3389/fonc.2019.01180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Geng ZM, Cai ZQ, Zhang Z, Tang ZH, Xue F, Chen C, Zhang D, Li Q, Zhang R, Li WZ, Wang L, Si SB. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma. World J Gastroenterol 2019; 25(37): 5655-5666 [PMID: 31602165 DOI: 10.3748/wjg.v25.i37.5655] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
13 Nag HH, Sachan A, Nekarakanti PK. Laparoscopic versus open extended cholecystectomy with bi-segmentectomy (s4b and s5) in patients with gallbladder cancer. J Minim Access Surg 2021;17:21-7. [PMID: 31603079 DOI: 10.4103/jmas.JMAS_98_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Kamada Y, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Tani M, Sato A, Tani R, Aoyama R, Sasaki Y, Zaima M. Surgical treatment of gallbladder cancer: An eight-year experience in a single center. World J Hepatol 2020; 12(9): 641-660 [PMID: 33033570 DOI: 10.4254/wjh.v12.i9.641] [Reference Citation Analysis]
15 Matsuyama R, Matsuo K, Mori R, Sugita M, Yamaguchi N, Kubota T, Kameda K, Mochizuki Y, Takagawa R, Kadokura T, Matsuda G, Kamiya N, Endo I. Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group. In Vivo 2021;35:1217-25. [PMID: 33622924 DOI: 10.21873/invivo.12372] [Reference Citation Analysis]
16 He S, Yu T, Khadaroo PA, Cai L, Chu Y, Wei F, Liang X. A Comparison Between the Prognosis of Simultaneous and Salvage Radical Resection in Incidental Gallbladder Cancer. Cancer Manag Res 2020;12:13469-78. [PMID: 33408519 DOI: 10.2147/CMAR.S286292] [Reference Citation Analysis]
17 Wensheng L, Bo Z, Qiangsheng H, Wenyan X, Shunrong J, Jin X, Quanxing N, Xianjun Y, Xiaowu X. MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine. Cancer Cell Int 2019;19:232. [PMID: 31516389 DOI: 10.1186/s12935-019-0948-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Zhang Y, Liu Y, Duan J, Wang H, Zhang Y, Qiao K, Wang J. Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response. Cell Cycle 2019;18:3337-50. [PMID: 31599189 DOI: 10.1080/15384101.2019.1676581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
19 Rizzo A, Ricci AD, Brandi G. IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver? Cancer Treat Res Commun 2021;27:100356. [PMID: 33799004 DOI: 10.1016/j.ctarc.2021.100356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Ayabe RI, Wach M, Ruff S, Martin S, Diggs L, Wiemken T, Hinyard L, Davis JL, Luu C, Hernandez JM. Primary Gallbladder Neuroendocrine Tumors: Insights into a Rare Histology Using a Large National Database. Ann Surg Oncol 2019;26:3577-85. [PMID: 31102094 DOI: 10.1245/s10434-019-07440-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
21 Nag HH, Nekarakanti PK, Sachan A, Nabi P, Tyagi S. Bi-segmentectomy versus wedge hepatic resection in extended cholecystectomy for T2 and T3 gallbladder cancer: A matched case-control study. Ann Hepatobiliary Pancreat Surg 2021;25:485-91. [PMID: 34845120 DOI: 10.14701/ahbps.2021.25.4.485] [Reference Citation Analysis]
22 Cho JK, Lee W, Jang JY, Kim HG, Kim JM, Kwag SJ, Park JH, Kim JY, Park T, Jeong SH, Ju YT, Jung EJ, Lee YJ, Hong SC, Jeong CY. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study. World J Surg Oncol. 2019;17:8. [PMID: 30616645 DOI: 10.1186/s12957-018-1556-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]